Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
HYDROXYZINE AA PHARMA INC Actual shortage 25MG Updated Report 2022-09-30 166471
INHIBACE PLUS CHEPLAPHARM ARZNEIMITTEL GMBH Resolved 12.5MG 5MG Updated Report 2022-09-30 166884
ALOMIDE NOVARTIS PHARMACEUTICALS CANADA INC Anticipated shortage 0.1% New Report 2022-09-29 170488
MAXIDEX NOVARTIS PHARMACEUTICALS CANADA INC Anticipated shortage 0.1% New Report 2022-09-29 170485
IZBA NOVARTIS PHARMACEUTICALS CANADA INC Anticipated shortage 0.003% New Report 2022-09-29 170482
TRAVATAN Z NOVARTIS PHARMACEUTICALS CANADA INC Actual shortage 0.004% Updated Report 2022-09-29 168148
SANDOSTATIN NOVARTIS PHARMACEUTICALS CANADA INC Actual shortage 100MCG Updated Report 2022-09-29 160174
STAXYN BAYER INC Resolved 10MG Updated Report 2022-09-29 62147
ESTRADOT 25 NOVARTIS PHARMACEUTICALS CANADA INC Actual shortage 25MCG Updated Report 2022-09-29 169233
ZYVOXAM PFIZER CANADA ULC Actual shortage 100MG Updated Report 2022-09-29 170399

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
BETOPTIC S NOVARTIS PHARMACEUTICALS CANADA INC To be discontinued 0.25% Updated Report 2022-09-29 170389
CIPROFLOXACIN INJECTION USP PFIZER CANADA ULC Discontinued 2MG Updated Report 2022-09-28 170299
CIPROFLOXACIN INJECTION USP PFIZER CANADA ULC To be discontinued 2MG New Report 2022-09-27 170302
INTEGRILIN MERCK CANADA INC To be discontinued 0.75MG Updated Report 2022-09-26 155790
INTEGRILIN MERCK CANADA INC To be discontinued 2MG Updated Report 2022-09-26 155794